Inhibiting Plasma Kallikrein for Hereditary Angioedema Prophylaxis

Aleena Banerji(Massachusetts General Hospital), Burt Adelman(Massachusetts General Hospital), Mustafa M. Shennak(Massachusetts General Hospital), Ryan Faucette(Massachusetts General Hospital), Harvey Kushner(Massachusetts General Hospital), Jon Kenniston(Massachusetts General Hospital), Carolyn Soo(Massachusetts General Hospital), Marc A. Riedl(University of California San Diego), Mark Davis‐Lorton(Winthrop-University Hospital), Ryan Iarrobino(Massachusetts General Hospital), Ahmad Al‐Ghazawi(Massachusetts General Hospital), Paula J. Busse(Massachusetts General Hospital), James Still(Massachusetts General Hospital), Timothy Craig(Penn State Milton S. Hershey Medical Center), H. James Wedner(Washington University in St. Louis), James Baker(Massachusetts General Hospital), Marco Cicardi, Yung Chyung(Massachusetts General Hospital), Robert Mensah(Massachusetts General Hospital), Daniel J. Sexton(Massachusetts General Hospital), Jonathan A. Bernstein(University of Cincinnati Medical Center), Joseph C. Biedenkapp(Massachusetts General Hospital), William R. Lumry(American Association for Respiratory Care), Chris Stevens(Massachusetts General Hospital), H. Henry Li(Massachusetts General Hospital), Joshua Jacobs(California Allergy and Asthma Medical Group), Christopher TenHoor(Massachusetts General Hospital), Richard F. Lockey(University of South Florida)
New England Journal of Medicine
February 17, 2017
Cited by 171


Related Papers